image
Healthcare - Biotechnology - NASDAQ - US
$ 3.86
-3.5 %
$ 165 M
Market Cap
-6.43
P/E
BALANCE SHEET
46.3 M ASSETS
-14.43%
5.63 M LIABILITIES
81.34%
40.7 M EQUITY
-20.25%
BALANCE SHEET DECOMPOSITION
Balance Sheet DiaMedica Therapeutics Inc.
image
Current Assets 44.6 M
Cash & Short-Term Investments 44.1 M
Receivables 236 K
Other Current Assets 227 K
Non-Current Assets 1.74 M
Long-Term Investments 0
PP&E 427 K
Other Non-Current Assets 1.31 M
95.26 %2.82 %Total Assets$46.3m
Current Liabilities 5.39 M
Accounts Payable 940 K
Short-Term Debt 0
Other Current Liabilities 4.45 M
Non-Current Liabilities 237 K
Long-Term Debt 0
Other Non-Current Liabilities 237 K
16.71 %79.08 %4.21 %Total Liabilities$5.6m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004
ASSETS
Cash & Cash Equivalents 3.0 4.5 4.7 4.7 7.4 3.9 16.8 1.4 1.7 0.2 0.2 2.5 2.3 2.7 2.8 0.6 2.5 3.5 0.3 0.3 7.64 K
Short Term Investments 41.1 48.4 28.8 40.4 20.1 4.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Receivables 0.2 0.4 82 K 0.1 0.3 0.8 0.8 80 K 52 K 9.62 K 8.41 K 0 0 50.4 K 0.2 47.9 K 31.1 K 95.5 K 57.1 K 30.2 K 20 K
Inventory 0 0 0 0.1 10 K 88 K 0 0 0 1.24 0.000001 1 0 1 1 1 1 1 0.678 2 0
Other Current Assets 0.2 0.4 0.3 0.2 74 K 0.1 0.4 61 K 65.2 K 32.9 K 53.9 K 81.7 K 0.1 33.7 K 83.8 K 17.2 K 42 K 50.1 K 9.88 K 13.5 K 0
Total Current Assets 44.6 53.7 33.8 45.4 27.9 8.8 18.0 1.5 1.9 0.2 0.3 2.6 2.5 2.7 3.1 0.7 2.5 3.6 0.3 0.3 27.6 K
PP&E 0.4 0.5 0.6 0.1 0.2 0.2 96 K 37 K 19.4 K 14.3 K 15.6 K 19.7 K 6.59 K 7.48 K 8.89 K 87.9 K 99.8 K 0.2 13.1 K 16.1 K 19.5 K
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0.3 1.4 0 5.9 0.5 0.4 0.5 0.4 0.2 0.2
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 1.3 0 0 0 0 0 0.3 0.3 0 0 0 1 0.0915 0.0784 0.422 0 1 0 1 1 0
Other Assets 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 1 0 0 0 1
Total Assets 46.3 54.2 34.4 45.6 28.1 9.1 18.3 1.8 1.9 0.2 0.3 2.9 3.8 6.3 9.1 1.2 3.0 4.3 0.7 0.6 0.2
LIABILITIES
Accounts Payable 0.9 0.9 0.7 0.5 1.1 0.2 0.5 0.5 0.2 0.7 1.0 0.4 1.1 0.1 0 0 0 0.3 53.3 K 56.5 K 0.7
Short Term Debt 0 83 K 0.1 98 K 0.1 0.1 5 K 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0.2
Other Current Liabilities 4.5 1.8 1.3 0.9 0.8 1.0 0.8 0.5 0.4 95.1 K 0.9 1.2 0.4 0.2 0.6 0.2 0.2 0 0 0 0.4
Total Current Liabilities 5.4 2.8 2.2 1.5 2.0 1.3 1.3 1.0 0.6 1.1 1.8 1.5 1.6 0.4 0.6 0.2 0.2 0.3 53.3 K 56.5 K 1.3
Long Term Debt 0 0.3 0.8 6 K 0.1 0.2 36 K 0 0 0.4 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 (0.4) 3 K 53 K (0.1) 18 K 0 0 1.04 K 0 0 0 0 0 0 0 0 0 0 0
Total Liabilities 5.6 3.1 2.6 1.5 2.1 1.4 1.3 1.0 0.6 1.5 1.8 1.5 1.6 0.4 0.6 0.2 0.2 0.3 53.3 K 56.5 K 1.3
EQUITY
Common Stock 0 0 0 0 0 0 0 0 41.0 28.1 32.3 K 33.6 K 30.2 K 0 0 0 0 0 0 0 0
Retained Earnings (140.0) (115.6) (96.2) (82.5) (68.9) (56.6) (46.0) (40.2) (46.7) (34.0) (38.9) (37.1) (31.8) (21.2) (14.9) (10.2) (6.6) (5.9) (3.0) (2.2) (2.0)
Other Accumulative Comprehensive Income/Loss 23 K 6 K 74 K 51 K 2 K 2 K 24 K 0.6 0.6 20.9 K 20.1 K 19.2 K 15.8 K 10.7 K 8.02 K 95 K 57.4 K 91.4 K 23.1 K 20.2 K 13.6 K
Total Equity 40.7 51.1 31.8 44.0 26.0 7.6 17.0 0.8 1.2 (1.2) (1.5) 1.4 2.3 6.0 8.5 1.0 2.8 4.1 0.7 0.5 (1.1)
Total Liabilities and Equity 46.3 54.2 34.4 45.6 28.1 9.1 18.3 1.8 1.9 0.2 0.3 2.9 3.8 6.3 9.1 1.2 3.0 4.3 0.7 0.6 0.2
SHARES OUTSTANDING
Common Shares Outstanding 40.4 32.6 26.4 20.8 15.7 12.0 7.7 5.9 4.7 3.6 3.1 2.7 2.4 2.3 1.4 1.0 0.9 0.8 0.9 0.4 0.3